Cologne – the Heart of Germany – will be the Host of BIO-Europe® 2016
CARLSBAD, California and COLOGNE, Germany, August 11, 2016 /PRNewswire/ —
Cologne, Germany will be the host of BIO-Europe® 2016 global life science partnering event, November 7-9, 2016.
BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. The event is a draw for executives in the life sciences who will gain direct access to service and manufacturing partners, innovative assets, and ideas from biotech companies ranging from very early stage to large, established companies. The event is also a critical business strategy for biotech companies to meet with pharma executives and investors to propel their drug development commercialization goals.
Cologne was chosen as the location for this year’s event due to its central European location in the Rhineland region of Germany. Cologne is easily accessible for companies across the globe, and is an important center of innovation with 450 life science companies and 121 firms focused on biotechnology.
“Cologne is a well-known European center for innovation, science and research,” said Anna Chrisman, Group Managing Director, EBD Group. “It is also a very active cluster, and home to one of the largest biotechnology parks in Germany. There is no better location to build business relationships than in Cologne’s knowledge-based industry in the heart of Europe.”
“With Cologne being located in the heart of the Rhineland, which celebrates its 20 years as a BioRegion in these days, BIO-Europe has chosen the perfect location for this year’s conference,” said Bernward Garthoff, Representative for Biotechnology of the German State of North Rhine-Westphalia. “Due to the close proximity of the important pharmaceutical and chemical industries, as well as many research institutes and the Cologne University Hospital, Cologne is one of the most innovative science and business regions with regard to Life Sciences in Germany and Europe, especially in the biopharma area. Over the last years, institutions such as the Max Planck Institute for Biology of Ageing have been focusing on the ageing processes and its associated diseases. We are looking forward to welcoming all attendees to the oldest city in Germany, where tradition and modernity belong together like Cologne and its cathedral.”
BIO-Europe 2015 was the largest to date, bringing together 3,520 executives from 1,886 companies and 55 countries, who engaged in over 19,000 one-to-one meetings to discuss asset deals and strategic collaborations. Last year’s edition reached a record high number of partnering meetings, up 7% from 2014, with 4,358 licensing opportunities on offer. There were 162 company presentations and 97 exhibitors.
Register for BIO-Europe 2016 before August 31, 2016 and save EUR 200 off the regular registration rate.
Watch video coverage from previous events, interviews with executives and thought leaders in the life science industry and premier content related to the biopharma industry on EBD Group’s Insight.
Additional links and information:
Follow BIO-Europe 2016 on Twitter: @EBDGroup (hashtag: BioEurope).
Online Press Kit service for BIO-Europe 2016 participants is available from PR Newswire to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America’, the fastest growing partnering event in North America
- Biotech Showcase’, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
- Biolatam®, facilitating partnering among global life sciences executives in Latin America’s vibrant life science hubs
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit http://www.ebdgroup.com.